Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo-Reference-Cited by-同舟云学术

Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo

Published:2020-01-29 Issue:5 Volume:177 Page:1150-1163
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Rogliani Paola¹^ORCID,Matera Maria Gabriella²,Facciolo Francesco³,Page Clive⁴,Cazzola Mario¹,Calzetta Luigino¹^ORCID

Affiliation:

1. Unit of Respiratory Medicine, Department of Experimental Medicine University of Rome “Tor Vergata” Rome Italy

2. Unit of Pharmacology, Department of Experimental Medicine University of Campania “Luigi Vanvitelli” Naples Italy

3. Thoracic Surgery Unit Regina Elena National Cancer Institute Rome Italy

4. Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science King's College London London UK

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.14909

Reference39 articles.

1. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors

2. The relationship between bronchial hyperresponsiveness to methacholine and airway smooth muscle structure and reactivity

3. Quantifying synergism/antagonism using nonlinear mixed-effects modeling: A simulation study

4. Adding a LAMA to ICS/LABA Therapy

5. Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhalational Drug Devices: Revisiting the Linchpin of Asthma Management;Journal of Personalized Medicine;2024-08-16

2. A clinician’s guide to single vs multiple inhaler therapy for COPD;Expert Review of Respiratory Medicine;2024-07-02

3. Precision cut lung slices: an integrated ex vivo model for studying lung physiology, pharmacology, disease pathogenesis and drug discovery;Respiratory Research;2024-06-01

4. Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement;Expert Opinion on Pharmacotherapy;2024-05-23

5. Managing Small Airway Disease in Patients with Severe Asthma: Transitioning from the “Silent Zone” to Achieving “Quiet Asthma”;Journal of Clinical Medicine;2024-04-17